2026 Q1 -tulosraportti
29 päivää sitten
‧29 min
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 3 357 | - | - | ||
| 2 331 | - | - | ||
| 25 | - | - | ||
| 1 418 | - | - | ||
| 1 473 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 160 623 | 160 623 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 160 623 | 160 623 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 21.5. | ||
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
·22 t sittenIt was very positive that there was a full house. A full house with over 100 participants for the expert session "Beyond creatinine: redefining hashtag#AKI diagnosis and decision-making in the hashtag#PICU" https://www.linkedin.com/company/bioporto-diagnostics-a-s/posts/?feedView=all·6 t sittenIt's a full house. This means that KDIGO's guidelines have been implemented. The fact that we haven't heard anything from KDIGO yet is also positive, because it has now been established that these guidelines they have published, in headlines, are also what one should expect them to be. KDIGO is now working on making the recommendations so detailed that users will not be in doubt about how they should be understood. See link about the 18 topics. Bonus info. Bioporto can continue, in the USA, almost as if nothing has happened, because there is the legal loophole, CLIA. See link CLIA is a compromise between the FDA and politicians, the FDA has always been politically controlled, but it became too much for the FDA while politicians thought it was too little. The short version. Politicians think with their wallets and the FDA with science. See link How to read the color codes. 🟢 Green: Low risk (Low risk) – Normal or slightly affected function without signs of disease. 🟡 Yellow: Moderately increased risk (Moderately increased risk) – Beginning loss of function or slight protein leakage. 🔵 Blue: High risk (High risk). This means that there is a significant decrease in kidney function (eGFR) and/or a significant amount of protein in the urine. The risk of worsening is high, and a clear treatment plan must be established. 🔴 Red: Very high risk (Very high risk) – Critically low function. Here there is a maximum risk of kidney failure and cardiac complications, which requires close follow-up with a kidney specialist. https://kdigo.org/guidelines/ Article from, Harvard Law, about FDA https://petrieflom.law.harvard.edu/2026/01/08/worst-of-both-worlds-fdas-funding-structure-corporate-capture-and-political-interference/ The prelude to the CLIA compromise (RUO) https://pmc.ncbi.nlm.nih.gov/articles/PMC1113977/- ·2 päivää sittenThe internet is God's gift to us investors. I may have found a website that informs every time Bioporto closes a contract, with the NGAL test, and when researchers want to use the NGAL test for their research, in any country within the EU. If it turns out that it works, would you then want this information? Please write below.
- ·2 päivää sittenI would like to make a correction to how it works when Bioporto sells NGAL tests for adults, only for research use. I have previously stated that Bioporto will sell NGAL tests for adults, only for research, to American hospitals, even though the FDA has not yet approved the test, and that is also correct, but I had understood that it was a gray area that the hospitals were moving into, and that is incorrect. The correct information is. If a hospital in the USA has a laboratory that is advanced enough and approved by the FDA for research, such as NGAL tests for adults, then it is completely legal. They call it CLIA. In the USA there are 490 university hospitals, all of which are allowed to use the NGAL test, only for research. Some of these university hospitals own a number of smaller hospitals and other treatment centers, and they can also use the NGAL test for adults, because the university hospitals run the test for them. The purely public hospitals must politely wait until the NGAL test for adults is approved by the FDA. That is the reason why Bioporto maintains its expectations and holds on to 60+ hospitals. CLIA https://www.cms.gov/regulations-and-guidance/legislation/clia/downloads/ldt-and-clia_faqs.pdf Number of university hospitals https://www.aamc.org/about-us/institutional-membership Example of a university hospital that owns smaller treatment centers https://www.massgeneralbrigham.org/en/patient-care/services-and-specialties/find-a-location/our-hospitals·2 päivää sittenNow that we have a handle on how it works over there, we should also keep an eye on the progress of getting more hospitals to participate in the research.
·2 päivää sitten3D Isn't it easier and safer to do like the rest of us and see how revenue develops each quarter. Then you avoid your many guesses and you wouldn't have, by the way, been lured by gold and green forests in recent years. - ·3 päivää sitten
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q1 -tulosraportti
29 päivää sitten
‧29 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·22 t sittenIt was very positive that there was a full house. A full house with over 100 participants for the expert session "Beyond creatinine: redefining hashtag#AKI diagnosis and decision-making in the hashtag#PICU" https://www.linkedin.com/company/bioporto-diagnostics-a-s/posts/?feedView=all·6 t sittenIt's a full house. This means that KDIGO's guidelines have been implemented. The fact that we haven't heard anything from KDIGO yet is also positive, because it has now been established that these guidelines they have published, in headlines, are also what one should expect them to be. KDIGO is now working on making the recommendations so detailed that users will not be in doubt about how they should be understood. See link about the 18 topics. Bonus info. Bioporto can continue, in the USA, almost as if nothing has happened, because there is the legal loophole, CLIA. See link CLIA is a compromise between the FDA and politicians, the FDA has always been politically controlled, but it became too much for the FDA while politicians thought it was too little. The short version. Politicians think with their wallets and the FDA with science. See link How to read the color codes. 🟢 Green: Low risk (Low risk) – Normal or slightly affected function without signs of disease. 🟡 Yellow: Moderately increased risk (Moderately increased risk) – Beginning loss of function or slight protein leakage. 🔵 Blue: High risk (High risk). This means that there is a significant decrease in kidney function (eGFR) and/or a significant amount of protein in the urine. The risk of worsening is high, and a clear treatment plan must be established. 🔴 Red: Very high risk (Very high risk) – Critically low function. Here there is a maximum risk of kidney failure and cardiac complications, which requires close follow-up with a kidney specialist. https://kdigo.org/guidelines/ Article from, Harvard Law, about FDA https://petrieflom.law.harvard.edu/2026/01/08/worst-of-both-worlds-fdas-funding-structure-corporate-capture-and-political-interference/ The prelude to the CLIA compromise (RUO) https://pmc.ncbi.nlm.nih.gov/articles/PMC1113977/
- ·2 päivää sittenThe internet is God's gift to us investors. I may have found a website that informs every time Bioporto closes a contract, with the NGAL test, and when researchers want to use the NGAL test for their research, in any country within the EU. If it turns out that it works, would you then want this information? Please write below.
- ·2 päivää sittenI would like to make a correction to how it works when Bioporto sells NGAL tests for adults, only for research use. I have previously stated that Bioporto will sell NGAL tests for adults, only for research, to American hospitals, even though the FDA has not yet approved the test, and that is also correct, but I had understood that it was a gray area that the hospitals were moving into, and that is incorrect. The correct information is. If a hospital in the USA has a laboratory that is advanced enough and approved by the FDA for research, such as NGAL tests for adults, then it is completely legal. They call it CLIA. In the USA there are 490 university hospitals, all of which are allowed to use the NGAL test, only for research. Some of these university hospitals own a number of smaller hospitals and other treatment centers, and they can also use the NGAL test for adults, because the university hospitals run the test for them. The purely public hospitals must politely wait until the NGAL test for adults is approved by the FDA. That is the reason why Bioporto maintains its expectations and holds on to 60+ hospitals. CLIA https://www.cms.gov/regulations-and-guidance/legislation/clia/downloads/ldt-and-clia_faqs.pdf Number of university hospitals https://www.aamc.org/about-us/institutional-membership Example of a university hospital that owns smaller treatment centers https://www.massgeneralbrigham.org/en/patient-care/services-and-specialties/find-a-location/our-hospitals·2 päivää sittenNow that we have a handle on how it works over there, we should also keep an eye on the progress of getting more hospitals to participate in the research.·2 päivää sitten3D Isn't it easier and safer to do like the rest of us and see how revenue develops each quarter. Then you avoid your many guesses and you wouldn't have, by the way, been lured by gold and green forests in recent years.
- ·3 päivää sitten
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 3 357 | - | - | ||
| 2 331 | - | - | ||
| 25 | - | - | ||
| 1 418 | - | - | ||
| 1 473 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 160 623 | 160 623 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 160 623 | 160 623 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 21.5. | ||
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
2026 Q1 -tulosraportti
29 päivää sitten
‧29 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: FactSet, Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q2 -tulosraportti 20.8. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q1 -tulosraportti 21.5. | ||
2025 Q4 -tulosraportti 26.3. | ||
2025 Q3 -tulosraportti 19.11.2025 | ||
2025 Q2 -tulosraportti 15.8.2025 | ||
2025 Q1 -tulosraportti 8.5.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
- ·22 t sittenIt was very positive that there was a full house. A full house with over 100 participants for the expert session "Beyond creatinine: redefining hashtag#AKI diagnosis and decision-making in the hashtag#PICU" https://www.linkedin.com/company/bioporto-diagnostics-a-s/posts/?feedView=all·6 t sittenIt's a full house. This means that KDIGO's guidelines have been implemented. The fact that we haven't heard anything from KDIGO yet is also positive, because it has now been established that these guidelines they have published, in headlines, are also what one should expect them to be. KDIGO is now working on making the recommendations so detailed that users will not be in doubt about how they should be understood. See link about the 18 topics. Bonus info. Bioporto can continue, in the USA, almost as if nothing has happened, because there is the legal loophole, CLIA. See link CLIA is a compromise between the FDA and politicians, the FDA has always been politically controlled, but it became too much for the FDA while politicians thought it was too little. The short version. Politicians think with their wallets and the FDA with science. See link How to read the color codes. 🟢 Green: Low risk (Low risk) – Normal or slightly affected function without signs of disease. 🟡 Yellow: Moderately increased risk (Moderately increased risk) – Beginning loss of function or slight protein leakage. 🔵 Blue: High risk (High risk). This means that there is a significant decrease in kidney function (eGFR) and/or a significant amount of protein in the urine. The risk of worsening is high, and a clear treatment plan must be established. 🔴 Red: Very high risk (Very high risk) – Critically low function. Here there is a maximum risk of kidney failure and cardiac complications, which requires close follow-up with a kidney specialist. https://kdigo.org/guidelines/ Article from, Harvard Law, about FDA https://petrieflom.law.harvard.edu/2026/01/08/worst-of-both-worlds-fdas-funding-structure-corporate-capture-and-political-interference/ The prelude to the CLIA compromise (RUO) https://pmc.ncbi.nlm.nih.gov/articles/PMC1113977/
- ·2 päivää sittenThe internet is God's gift to us investors. I may have found a website that informs every time Bioporto closes a contract, with the NGAL test, and when researchers want to use the NGAL test for their research, in any country within the EU. If it turns out that it works, would you then want this information? Please write below.
- ·2 päivää sittenI would like to make a correction to how it works when Bioporto sells NGAL tests for adults, only for research use. I have previously stated that Bioporto will sell NGAL tests for adults, only for research, to American hospitals, even though the FDA has not yet approved the test, and that is also correct, but I had understood that it was a gray area that the hospitals were moving into, and that is incorrect. The correct information is. If a hospital in the USA has a laboratory that is advanced enough and approved by the FDA for research, such as NGAL tests for adults, then it is completely legal. They call it CLIA. In the USA there are 490 university hospitals, all of which are allowed to use the NGAL test, only for research. Some of these university hospitals own a number of smaller hospitals and other treatment centers, and they can also use the NGAL test for adults, because the university hospitals run the test for them. The purely public hospitals must politely wait until the NGAL test for adults is approved by the FDA. That is the reason why Bioporto maintains its expectations and holds on to 60+ hospitals. CLIA https://www.cms.gov/regulations-and-guidance/legislation/clia/downloads/ldt-and-clia_faqs.pdf Number of university hospitals https://www.aamc.org/about-us/institutional-membership Example of a university hospital that owns smaller treatment centers https://www.massgeneralbrigham.org/en/patient-care/services-and-specialties/find-a-location/our-hospitals·2 päivää sittenNow that we have a handle on how it works over there, we should also keep an eye on the progress of getting more hospitals to participate in the research.·2 päivää sitten3D Isn't it easier and safer to do like the rest of us and see how revenue develops each quarter. Then you avoid your many guesses and you wouldn't have, by the way, been lured by gold and green forests in recent years.
- ·3 päivää sitten
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Määrä
Osto
-
Myynti
Määrä
-
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 3 357 | - | - | ||
| 2 331 | - | - | ||
| 25 | - | - | ||
| 1 418 | - | - | ||
| 1 473 | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 160 623 | 160 623 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Anonyymi | 160 623 | 160 623 | 0 | 0 |